drugset / Trial / NCT04752631

MRI-guided thrOmbolysis for Stroke bEyond Time Window by TNK

NCT04752631

Phase 4 Completed 80 enrolled General Hospital of Shenyang Military Region
RandomizedParallel-groupSingle-blindTreatment

Summary

This is an open label multicentre trial, evaluating the utility of MRI-guided thrombolysis for stroke beyond time window by Tenecteplase (TNK-tPA). This exploratory study was to describe the feasibility and outcome of thrombolytic therapy with TNK-tPA in 4.5-24 hours after stroke guided by a mismatch between diffusion-weighted imaging and FLAIR in the region of ischemia.

Timeline

Start
2021-03-09
Primary completion
2022-07-24
Completion
2022-07-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Tenecteplase Protein / enzyme biologic 0.25 mg/kg

Indications